Sidney, John
La Jolla Institute for Immunology
16 papers on CoChatORCID 0000-0002-0987-405X
Most cited papers
- Verified
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 1,120
- Verified
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 866
- Verified
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Tarke, A., Coelho, C. H., Zhang, Z., Dan, J. M., Yu, E. D., Methot, N., Bloom, N. I., Goodwin, B., Phillips, E., Mallal, S., et al. (2022) · Cell
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 858
- Verified
HLA class I supertypes: a revised and updated classification
Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A. (2008) · BMC Immunology
vaccines and immunoinformatics approachesImmunotherapy and Immune Responses
Cited by 775
- Verified
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 706
- Verified
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics
vaccines and immunoinformatics approachesImmunotherapy and Immune Responses
Cited by 635
- Verified
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., et al. (2021) · Cell Reports Medicine
vaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research
Cited by 540
- Verified
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
Wells, D. K., van Buuren, M. M., Dang, K. K., Hubbard-Lucey, V. M., Sheehan, K. C. F., Campbell, K. M., Lamb, A., Ward, J. P., Sidney, J., Blazquez, A. B., et al. (2020) · Cell
vaccines and immunoinformatics approachesCancer Immunotherapy and Biomarkers
Cited by 538
- Verified
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Grifoni, A., Sidney, J., Vita, R., Peters, B., Crotty, S., Weiskopf, D., & Sette, A. (2021) · Cell Host & Microbe
vaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research
Cited by 314
- Verified
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., et al. (2021) · Cell
vaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research
Cited by 147
- Verified
Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection
Weiskopf, D., Angelo, M. A., Sidney, J., Peters, B., Shresta, S., & Sette, A. (2014) · Journal of Virology
Mosquito-borne diseases and controlvaccines and immunoinformatics approaches
Cited by 90
- Verified
Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection
Rawson, P. M., Molette, C., Videtta, M., Altieri, L., Franceschini, D., Donato, T., Finocchi, L., Propato, A., Paroli, M., Meloni, F., et al. (2007) · Nature Medicine
HIV Research and TreatmentImmunotherapy and Immune Responses
Cited by 86
- Verified
Cellular immune response to cryptic epitopes during therapeutic gene transfer
Li, C., Goudy, K., Hirsch, M., Asokan, A., Fan, Y., Alexander, J., Sun, J., Monahan, P., Seiber, D., Sidney, J., et al. (2009) · Proceedings of the National Academy of Sciences
Virus-based gene therapy researchImmunotherapy and Immune Responses
Cited by 79
- Verified
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
Sagan, S. A., Moinfar, Z., Moseley, C. E., Dandekar, R., Spencer, C. M., Verkman, A. S., Ottersen, O. P., Sobel, R. A., Sidney, J., Sette, A., et al. (2023) · Proceedings of the National Academy of Sciences
Multiple Sclerosis Research StudiesT-cell and B-cell Immunology
Cited by 25
- Verified
Thioamide Analogues of MHC I Antigen Peptides
Gibadullin, R., Morris, R. K., Niu, J., Sidney, J., Sette, A., & Gellman, S. H. (2023) · Journal of the American Chemical Society
Chemical Synthesis and Analysisvaccines and immunoinformatics approaches
Cited by 17
- Verified
β-amino acid substitution in the SIINFEKL antigen alters immunological recognition
Rastogi, I., Mannone, J. A., Gibadullin, R., Moseman, J. E., Sidney, J., Sette, A., McNeel, D. G., & Gellman, S. H. (2025) · Cancer Biology & Therapy
Immunotherapy and Immune ResponsesChemical Synthesis and Analysis
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free